Play Earnings CallPlay Earnings Call
Neurocrine Biosciences, Inc. (NBIX) Piper Sandler 37th Annual Healthcare Conference December 2, 2025 9:30 AM EST
Company Participants
Matthew Abernethy – Chief Financial Officer
Eric Benevich – Chief Commercial Officer
Todd Tushla
Conference Call Participants
David Amsellem – Piper Sandler & Co., Research Division
Presentation
David Amsellem
Piper Sandler & Co., Research Division
Well, let’s kick things off. This is David Amsellem from the Piper Sandler biopharma research team. We’re delighted to have Neurocrine here. We have Matt Abernethy, CFO. We have Eric Benevich, Chief Commercial Officer. We have Todd Tushla, director of Investor Relations. Thanks, gentlemen, for joining us.
So it’s been quite a year. So I would love to turn it over to Matt for just a few opening remarks on, I guess, a reflection on what’s been to say the least, an interesting year, both for Neurocrine and for the biotech space, we’re at large.
Matthew Abernethy
Chief Financial Officer
Well, I like how you said delighted to have us here. I think this year, anybody who thinks it’s been a delight, I think, is fooling themselves. I was talking to investor before this, and they were reflecting on we’re sitting here in a really good space — spot from a stock performance, but getting here, man, it’s been a slog, I think, for the entire industry. So I think that there’s a lot going on in the industry and in the sector. And then for us, as a company, we’re actually executing quite well. I think you’d agree with that.
It is early. It is 6:30 a.m. back in California. And so I thought maybe I’d share a little bit about what motivated me to get out of bed this morning and what motivates us to get out of bed every single morning. The 3 things that come top of mind
